Received Jun 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Inflammed arm, general inflammation; Headache; This non-serious case was reported by a consumer and described the occurrence of inflammation in a 51-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (12 years ago), chickenpox (had chickenpox as a child), asthma and hashimoto's disease. Previously administered products included Shingles vaccine (Received 1st dose of Shingles vaccine in March, with no issues.). Concurrent medical conditions included hypothyroidism and seasonal allergy. Concomitant products included levothyroxine. On 05-JUN-2025, the patient received the 2nd dose of Shingles vaccine. On 05-JUN-2025, less than a day after receiving Shingles vaccine, the patient experienced inflammation (Verbatim: Inflammed arm, general inflammation) and headache (Verbatim: Headache). The patient was treated with ibuprofen (Advil). The outcome of the inflammation and headache were not resolved. It was unknown if the reporter considered the inflammation and headache to be related to Shingles vaccine. It was unknown if the company considered the inflammation and headache to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 09-JUN-2025 The patient had inflammed arm, general inflammation and headache. The first vaccine did not have any reaction like this. The patient had been using ice packs and advil for 4 days to help ease the reaction.
Hypothyroidism
Medical History/Concurrent Conditions: Asthma; Chickenpox (had chickenpox as a child); Hashimoto's disease; Seasonal allergy; Shingles (12 years ago)
LEVOTHYROXINE